Zender L - Search Results

1

VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo.

Zender L, Kühnel F, Köck R, Manns M, Kubicka S. Zender L, et al. Cancer Gene Ther. 2002 Jun;9(6):489-96. doi: 10.1038/sj.cgt.7700465. Cancer Gene Ther. 2002. PMID: 12032659

2

Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors.

Zender L, Köck R, Eckhard M, Frericks B, Gösling T, Gebhardt T, Drobek S, Galanski M, Kühnel F, Manns M, Kubicka S. Zender L, et al. Gastroenterology. 2002 Aug;123(2):608-18. doi: 10.1053/gast.2002.34756. Gastroenterology. 2002. PMID: 12145813

3

Involvement of TRAIL and its receptors in viral hepatitis.

Mundt B, Kühnel F, Zender L, Paul Y, Tillmann H, Trautwein C, Manns MP, Kubicka S. Mundt B, et al. Among authors: zender l. FASEB J. 2003 Jan;17(1):94-6. doi: 10.1096/fj.02-0537fje. Epub 2002 Nov 15. FASEB J. 2003. PMID: 12475902

4

A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.

Wirth T, Zender L, Schulte B, Mundt B, Plentz R, Rudolph KL, Manns M, Kubicka S, Kühnel F. Wirth T, et al. Among authors: zender l. Cancer Res. 2003 Jun 15;63(12):3181-8. Cancer Res. 2003. PMID: 12810646

5

Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.

Kühnel F, Zender L, Wirth T, Schulte B, Trautwein C, Manns M, Kubicka S. Kühnel F, et al. Among authors: zender l. Cancer Gene Ther. 2004 Jan;11(1):28-40. doi: 10.1038/sj.cgt.7700632. Cancer Gene Ther. 2004. PMID: 14681724

6

Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.

Wirth T, Kühnel F, Fleischmann-Mundt B, Woller N, Djojosubroto M, Rudolph KL, Manns M, Zender L, Kubicka S. Wirth T, et al. Among authors: zender l. Cancer Res. 2005 Aug 15;65(16):7393-402. doi: 10.1158/0008-5472.CAN-04-3664. Cancer Res. 2005. PMID: 16103092

7

Targeting of p53-transcriptional dysfunction by conditionally replicating adenovirus is not limited by p53-homologues.

Kühnel F, Gürlevik E, Wirth TC, Strüver N, Malek NP, Müller-Schilling M, Manns MP, Carnero A, Zender L, Kubicka S. Kühnel F, et al. Among authors: zender l. Mol Ther. 2010 May;18(5):936-46. doi: 10.1038/mt.2009.298. Epub 2009 Dec 29. Mol Ther. 2010. PMID: 20040911 Free PMC article.

8

Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity.

Gürlevik E, Woller N, Strüver N, Schache P, Kloos A, Manns MP, Zender L, Kühnel F, Kubicka S. Gürlevik E, et al. Among authors: zender l. Mol Ther. 2010 Nov;18(11):1972-82. doi: 10.1038/mt.2010.163. Epub 2010 Aug 10. Mol Ther. 2010. PMID: 20700112 Free PMC article.

9

p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesis.

Kubicka S, Kühnel F, Zender L, Rudolph KL, Plümpe J, Manns M, Trautwein C. Kubicka S, et al. Among authors: zender l. J Biol Chem. 1999 Nov 5;274(45):32137-44. doi: 10.1074/jbc.274.45.32137. J Biol Chem. 1999. PMID: 10542249 Free article.

10

IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.

Tietze MK, Wuestefeld T, Paul Y, Zender L, Trautwein C, Manns MP, Kubicka S. Tietze MK, et al. Among authors: zender l. Cancer Gene Ther. 2000 Oct;7(10):1315-23. doi: 10.1038/sj.cgt.7700247. Cancer Gene Ther. 2000. PMID: 11059688

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters